MiR-200c-3p regulates pyroptosis by targeting SLC30A7 in diabetic retinopathy. (24th April 2022)

• Record Type: Journal Article
• Authors: Li, Weina; Yang, Sheng; Chen, Guangsheng; He, Shiping
• Is Part Of: Human & experimental toxicology. Volume 41(2022)
• Publication Date: 2022-04-24
• Subjects: Diabetic retinopathy -- MiR-200c-3p -- SLC30A7 -- pyroptosis; Toxicology -- Periodicals; 615.9
• DOI: 10.1177/09603271221099589
• Languages: English
• ISSNs: 0960-3271

Abstract

Clinical relevance: MicroRNAs (miRNAs) have been reported to be involved in the progression of various diseases. Studying the regulatory mechanisms of miRNAs can help clinical treatment. Background: Diabetic retinopathy (DR) is one of the complications of diabetes. The objective of this study was to elucidate the underlying molecular mechanisms by which miR-200c-3p regulates the pyroptosis of DR cell. Methods: Human retinal microvascular endothelial cells (HRMECs) and high glucose (HG) cultures established DR cell model in vitro. RT-qPCR is used to detect the expression level of miRNAs. CCK-8 assays and flow cytometry are used to detect apoptosis of HRMECs cell. Western blotting is used to detect cleaved caspase-3, cleaved caspase-1, and N-GSDMD proteins levels in HRMECs. The ELISA assay is used to detect the expression of IL-1β and IL-18. Predict and validate potential binding sites between miR-200c-3p and SLC30A7 by dual luciferase reporter gene analysis. Results: The results showed that HG caused damage to HRMECs through the pyroptosis pathway rather than the apoptosis pathway. MiR-200c-3p is highly expressed in HG induced-HRMECs, and knockdown of miR-200c-3p mitigates HG-induced HRMECs pyroptosis. MiR-200c-3p negatively targets SLC30A7 in HRMECs, and miR-200c-3p regulates pyroptosis of HG-induced HRMECs by targeting SLC30A7. Conclusion: The results suggest that miR-200c-3p might be a promising interference target for DR prevention and treatment. The results of current study may provide new insights into development of therapeutic strategies for DR.